Clinical Trials Directory

Trials / Completed

CompletedNCT07313137

Antiplatelet Use in Dementia Subtypes

Antiplatelet Use in All-Cause Dementia and Dementia Subtypes Among Older Adults: A Population-Based Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
683 (actual)
Sponsor
Gulhane Training and Research Hospital · Other Government
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This population-based retrospective cohort study aimed to evaluate the appropriateness of antiplatelet therapy use among older adults with all-cause dementia and across different dementia subtypes. Medical records of patients aged 65 years and older who were evaluated at a tertiary-level geriatric outpatient clinic were reviewed. Dementia subtypes were classified according to internationally accepted diagnostic criteria. Patterns of antiplatelet use were assessed in accordance with current guideline recommendations. The study sought to determine the appropriateness of antiplatelet use across dementia subtypes and to describe real-world prescribing practices in this population.

Conditions

Timeline

Start date
2016-12-01
Primary completion
2025-03-01
Completion
2025-03-01
First posted
2025-12-31
Last updated
2025-12-31

Source: ClinicalTrials.gov record NCT07313137. Inclusion in this directory is not an endorsement.